SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-004426
Filing Date
2024-01-08
Accepted
2024-01-08 16:17:00
Documents
13
Period of Report
2024-01-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d685245d8k.htm   iXBRL 8-K 27404
  Complete submission text file 0001193125-24-004426.txt   189128

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA nuvb-20240108.xsd EX-101.SCH 4248
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nuvb-20240108_def.xml EX-101.DEF 13886
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE nuvb-20240108_lab.xml EX-101.LAB 23297
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nuvb-20240108_pre.xml EX-101.PRE 14854
7 EXTRACTED XBRL INSTANCE DOCUMENT d685245d8k_htm.xml XML 5805
Mailing Address 357 TEHAMA STREET, FLOOR 3 SAN FRANCISCO CA 94103
Business Address 357 TEHAMA STREET, FLOOR 3 SAN FRANCISCO CA 94103 (415) 754-3517
Nuvation Bio Inc. (Filer) CIK: 0001811063 (see all company filings)

IRS No.: 850862255 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39351 | Film No.: 24520344
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)